Retatrutide 20 mg
CA$150.00
Retatrutide is an investigational (not yet widely approved) injectable medication designed for obesity and metabolic disorders. It activates three hormone receptors—GLP‑1, GIP, and glucagon—making it a “triple agonist.” This combined action significantly reduces appetite, boosts energy expenditure, improves blood sugar control, and has shown very large weight‑loss effects in early clinical trials.